BioSpace News Archive

The escalating need for an advanced ultrasonic testing method in the healthcare sector may help the global phased array ultrasonic transducer market gain immense growth prospects across the forecast period of 2019-2029.

The prevalence of visual impairment disorders is at an all-time high around the world.

The global implantable neurostimulators market is foreseen to register promising growth trajectory during the forecast period of 2019 to 2029.

-- Monotherapy and combination studies continue to demonstrate best - in - class potential of MDNA11 -- B ispecific IL-2/IL-13 Superkine demonstrates the potential to treat immunologically “cold” tumors

First Phase 3 trial in eosinophilic esophagitis (EoE) to show a biologic medicine significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMO), today announced plans to significantly expand its biology capabilities at its integrated R&D campus in Hyderabad, India with a dedicated 75,000 sq. ft. facility and an augmented team of 170 biologists.

LifeScan, a world leader in blood glucose monitoring serving 20 million people with diabetes and the maker of the iconic OneTouch® brand, today announced its partnership with Truepill™, the digital health platform powering consumer health experiences through its API-connected infrastructure.

The National Kidney Foundation (NKF) is pleased to announce that Dr. Paul M. Palevsky, a nephrologist and Professor of Medicine, University of Pittsburgh School of Medicine and Chief of Kidney Medicine at the VA Pittsburgh Healthcare System, has begun his two-year term as president of NKF’s Board of Directors.

Syntropy, a technology company specializing in healthcare data integration and collaboration solutions, today announced it is joining forces with MITRE to provide data integration support for the mCODE™ (minimal Common Oncology Data Elements) data standard.

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, announced that the company will be participating in two upcoming investor conferences.